Health Sciences → Medicine → Pharmacology
Treatment of Major Depression
This cluster of papers focuses on the molecular mechanisms and treatment strategies for depression, with a particular emphasis on antidepressant medications, ketamine, NMDA receptor antagonists, and neurobiological pathways. It covers topics such as treatment-resistant depression, glutamate signaling, cognitive impairment, and synaptic plasticity. The papers also discuss clinical guidelines and the evaluation of outcomes for various treatment approaches.
63.8K works worldwide1.4M citations
DepressionAntidepressantKetamineNMDA ReceptorTreatment-Resistant DepressionNeurobiological MechanismsGlutamate SignalingCognitive ImpairmentSynaptic PlasticityClinical Guidelines
Journals publishing in this area
Articles on Scinovex in this research area
3 articles, most cited first
- Serotonin transporter gene polymorphisms, 5-httlpr variants, and their association with major depressive disorder susceptibilityInternational Journal of Advanced Biochemistry Research · 2025 · 0 citations
- Synaptic plasticity mechanisms underlying long-term potentiation in hippocampal CA1 neuronsInternational Journal of Biology Sciences · 2025 · 0 citations · AI summary
- Biochemical analysis of neurotransmitter dysregulation in major depressive disorder: Integrating monoamine, inflammatory, and neuroendocrine biomarkersInternational Journal of Advanced Biochemistry Research · 2024 · 0 citations
